# Abivax S.A.: financial statements, quarterly

ABVX · Nasdaq · CIK 1956827 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/abvx.md) · [Financials](/companies/abvx/financials.md) · [Filings](/companies/abvx/filings.md) · [Insiders](/companies/abvx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/abvx/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2020-12-31) | period not labelled (2021-12-31) | period not labelled (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [29.3](/filings/0001956827-24-000007.md) | [60.7](/filings/0001956827-25-000010.md) | [27.0](/filings/0001956827-26-000012.md) | [252](/filings/0001956827-26-000012.md) | [144](/filings/0001956827-26-000012.md) | [517](/filings/0001956827-26-000012.md) |
| Current assets | $m | not reported | [75.5](/filings/0001956827-24-000007.md) | [36.2](/filings/0001956827-25-000010.md) | [286](/filings/0001956827-26-000012.md) | [171](/filings/0001956827-26-000012.md) | [551](/filings/0001956827-26-000012.md) |
| Total assets | $m | not reported | [109](/filings/0001956827-24-000007.md) | [75.5](/filings/0001956827-25-000010.md) | [327](/filings/0001956827-26-000012.md) | [205](/filings/0001956827-26-000012.md) | [584](/filings/0001956827-26-000012.md) |
| Current liabilities | $m | not reported | [32.3](/filings/0001956827-24-000007.md) | [51.5](/filings/0001956827-25-000010.md) | [90.7](/filings/0001956827-26-000012.md) | [94.0](/filings/0001956827-26-000012.md) | [63.0](/filings/0001956827-26-000012.md) |
| Shareholders' equity | $m | [1.7](/filings/0001956827-24-000007.md) | [25.9](/filings/0001956827-25-000010.md) | [7.2](/filings/0001956827-26-000012.md) | [196](/filings/0001956827-26-000012.md) | [40.6](/filings/0001956827-26-000012.md) | [455](/filings/0001956827-26-000012.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 78,536,412 at 2025-12-31, from the cover of the [20-F filed 2026-03-23](/filings/0001956827-26-000012.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.